These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

356 related articles for article (PubMed ID: 22446104)

  • 21. Inhibiting proteasomal proteolysis sustains estrogen receptor-alpha activation.
    Fan M; Nakshatri H; Nephew KP
    Mol Endocrinol; 2004 Nov; 18(11):2603-15. PubMed ID: 15284335
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Estrogen receptor (ER) expression and function in the pregnant human myometrium: estradiol via ERα activates ERK1/2 signaling in term myometrium.
    Welsh T; Johnson M; Yi L; Tan H; Rahman R; Merlino A; Zakar T; Mesiano S
    J Endocrinol; 2012 Feb; 212(2):227-38. PubMed ID: 22068927
    [TBL] [Abstract][Full Text] [Related]  

  • 23. S-palmitoylation modulates estrogen receptor alpha localization and functions.
    Marino M; Ascenzi P; Acconcia F
    Steroids; 2006 Apr; 71(4):298-303. PubMed ID: 16274718
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Estrogen regulates JNK1 genomic localization to control gene expression and cell growth in breast cancer cells.
    Sun M; Isaacs GD; Hah N; Heldring N; Fogarty EA; Kraus WL
    Mol Endocrinol; 2012 May; 26(5):736-47. PubMed ID: 22446103
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Estrogen receptor α L429 and A430 regulate 17β-estradiol-induced cell proliferation via CREB1.
    Pesiri V; Totta P; Segatto M; Bianchi F; Pallottini V; Marino M; Acconcia F
    Cell Signal; 2015 Dec; 27(12):2380-8. PubMed ID: 26348925
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Activation of estrogen receptor α by estradiol and cisplatin induces platinum-resistance in ovarian cancer cells.
    Matsumura S; Ohta T; Yamanouchi K; Liu Z; Sudo T; Kojimahara T; Seino M; Narumi M; Tsutsumi S; Takahashi T; Takahashi K; Kurachi H; Nagase S
    Cancer Biol Ther; 2017 Sep; 18(9):730-739. PubMed ID: 27689466
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Real-time measurement of E2: ERα transcriptional activity in living cells.
    Cipolletti M; Leone S; Bartoloni S; Busonero C; Acconcia F
    J Cell Physiol; 2020 Oct; 235(10):6697-6710. PubMed ID: 31989654
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differential utilization of nuclear and extranuclear receptor signaling pathways in the actions of estrogens, SERMs, and a tissue-selective estrogen complex (TSEC).
    Madak-Erdogan Z; Gong P; Katzenellenbogen BS
    J Steroid Biochem Mol Biol; 2016 Apr; 158():198-206. PubMed ID: 26689478
    [TBL] [Abstract][Full Text] [Related]  

  • 29. G protein-coupled receptor 30 (GPR30) mediates gene expression changes and growth response to 17beta-estradiol and selective GPR30 ligand G-1 in ovarian cancer cells.
    Albanito L; Madeo A; Lappano R; Vivacqua A; Rago V; Carpino A; Oprea TI; Prossnitz ER; Musti AM; Andò S; Maggiolini M
    Cancer Res; 2007 Feb; 67(4):1859-66. PubMed ID: 17308128
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A high throughput method to study the physiology of E2:ERα signaling in breast cancer cells.
    Leone S; Busonero C; Acconcia F
    J Cell Physiol; 2018 May; 233(5):3713-3722. PubMed ID: 29091270
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nuclear and extranuclear pathway inputs in the regulation of global gene expression by estrogen receptors.
    Madak-Erdogan Z; Kieser KJ; Kim SH; Komm B; Katzenellenbogen JA; Katzenellenbogen BS
    Mol Endocrinol; 2008 Sep; 22(9):2116-27. PubMed ID: 18617595
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Liposomes and drug-in-cyclodextrin-in-liposomes formulations encapsulating 17β-estradiol: An innovative drug delivery system that prevents the activation of the membrane-initiated steroid signaling (MISS) of estrogen receptor α.
    Gallez A; Palazzo C; Blacher S; Tskitishvili E; Noël A; Foidart JM; Evrard B; Pequeux C; Piel G
    Int J Pharm; 2020 Jan; 573():118861. PubMed ID: 31765774
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The nutritional flavanone naringenin triggers antiestrogenic effects by regulating estrogen receptor alpha-palmitoylation.
    Galluzzo P; Ascenzi P; Bulzomi P; Marino M
    Endocrinology; 2008 May; 149(5):2567-75. PubMed ID: 18239068
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 17beta-Estradiol inhibits matrix metalloproteinase-2 transcription via MAP kinase in fibroblasts.
    Mahmoodzadeh S; Dworatzek E; Fritschka S; Pham TH; Regitz-Zagrosek V
    Cardiovasc Res; 2010 Mar; 85(4):719-28. PubMed ID: 19861308
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dynamin II is required for 17β-estradiol signaling and autophagy-based ERα degradation.
    Totta P; Busonero C; Leone S; Marino M; Acconcia F
    Sci Rep; 2016 Mar; 6():23727. PubMed ID: 27009360
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Palmitoylation of estrogen receptors is essential for neuronal membrane signaling.
    Meitzen J; Luoma JI; Boulware MI; Hedges VL; Peterson BM; Tuomela K; Britson KA; Mermelstein PG
    Endocrinology; 2013 Nov; 154(11):4293-304. PubMed ID: 24008343
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Upregulation of TLR2 expression is induced by estrogen via an estrogen-response element (ERE).
    Li X; Li M; Bai X
    Arch Biochem Biophys; 2014 May; 549():26-31. PubMed ID: 24508688
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interplay between estrogen receptor and AKT in estradiol-induced alternative splicing.
    Bhat-Nakshatri P; Song EK; Collins NR; Uversky VN; Dunker AK; O'Malley BW; Geistlinger TR; Carroll JS; Brown M; Nakshatri H
    BMC Med Genomics; 2013 Jun; 6():21. PubMed ID: 23758675
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The ERα membrane pool modulates the proliferation of pituitary tumours.
    Sosa LDV; Petiti JP; Picech F; Chumpen S; Nicola JP; Perez P; De Paul A; Valdez-Taubas J; Gutierrez S; Torres AI
    J Endocrinol; 2019 Feb; 240(2):229-241. PubMed ID: 30400032
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Essential role of endogenous prolactin and CDK7 in estrogen-induced upregulation of the prolactin receptor in breast cancer cells.
    Kavarthapu R; Dufau ML
    Oncotarget; 2017 Apr; 8(16):27353-27363. PubMed ID: 28423697
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.